Tang Capital Management as of March 31, 2020
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 25 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Odonate Therapeutics Ord | 54.6 | $389M | 14M | 27.61 | |
| Relmada Therapeutics (RLMD) | 6.2 | $44M | 1.3M | 34.11 | |
| Rocket Pharmaceuticals (RCKT) | 5.8 | $41M | 3.0M | 13.95 | |
| Heron Therapeutics (HRTX) | 4.8 | $34M | 2.9M | 11.74 | |
| La Jolla Pharmaceuticl Com Par | 4.8 | $34M | 8.1M | 4.20 | |
| Anaptysbio Inc Common (ANAB) | 4.5 | $32M | 2.3M | 14.13 | |
| Bio-Rad Laboratories (BIO) | 3.9 | $28M | 80k | 350.56 | |
| United Therapeutics Corporation (UTHR) | 2.8 | $20M | 208k | 94.83 | |
| Avrobio Ord (AVRO) | 2.2 | $16M | 1.0M | 15.56 | |
| Evolus (EOLS) | 1.9 | $14M | 3.3M | 4.15 | |
| Sangamo Biosciences (SGMO) | 1.8 | $13M | 2.0M | 6.37 | |
| Eagle Pharmaceuticals (EGRX) | 1.7 | $12M | 256k | 46.00 | |
| Puma Biotechnology (PBYI) | 0.9 | $6.8M | 800k | 8.44 | |
| Coherus Biosciences (CHRS) | 0.8 | $5.7M | 350k | 16.22 | |
| Lifesci Acquisition Corp unit 03/31/2025 | 0.7 | $5.0M | 500k | 10.00 | |
| Prothena (PRTA) | 0.6 | $4.5M | 424k | 10.70 | |
| Radius Health | 0.5 | $3.9M | 300k | 13.00 | |
| Vanda Pharmaceuticals (VNDA) | 0.4 | $3.1M | 300k | 10.36 | |
| Cytomx Therapeutics (CTMX) | 0.3 | $2.3M | 300k | 7.67 | |
| G1 Therapeutics (GTHX) | 0.3 | $1.9M | 170k | 11.02 | |
| Enanta Pharmaceuticals (ENTA) | 0.1 | $693k | 14k | 51.40 | |
| Intra Cellular Therapies (ITCI) | 0.1 | $637k | 41k | 15.37 | |
| Chimerix (CMRX) | 0.1 | $621k | 431k | 1.44 | |
| Nucana Plc american depositary shares (NCNA) | 0.1 | $583k | 100k | 5.83 | |
| United Parcel Service (UPS) | 0.0 | $93k | 1.0k | 93.00 |
